This is a HIPAA-compliant webform. All responses are confidential and used only for contacting you about our studies. Thank you for your interest and willingness to make a difference. Our staff will be in touch with you shortly with more information.
DO YOU HAVE OCD AND ARE STRUGGLING TO FIND EFFECTIVE TREATMENT?
This study is evaluating the efficacy of a new medication as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment. Study sponsored by Biohaven Pharmaceuticals in collaboration with NOCD.
Length of Study: 12-18 weeks with 7 on-site visits
ELIGIBILITY:
You may be eligible to participate in this study if you:
If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. Apply now.